ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 277 filers reported holding ICU MED INC in Q3 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,399,402 | -37.4% | 28,564 | -6.3% | 0.02% | -33.3% |
| Q2 2023 | $5,432,657 | +5.9% | 30,488 | -2.0% | 0.03% | -2.9% |
| Q1 2023 | $5,130,586 | +3.8% | 31,102 | -0.9% | 0.03% | -2.9% |
| Q4 2022 | $4,943,770 | +3.6% | 31,393 | -1.0% | 0.04% | 0.0% |
| Q3 2022 | $4,774,000 | -12.5% | 31,700 | -4.5% | 0.04% | -5.4% |
| Q2 2022 | $5,455,000 | -27.5% | 33,185 | -1.8% | 0.04% | -9.8% |
| Q1 2022 | $7,521,000 | -6.1% | 33,779 | +0.1% | 0.04% | +2.5% |
| Q4 2021 | $8,013,000 | 0.0% | 33,762 | -1.7% | 0.04% | -7.0% |
| Q3 2021 | $8,013,000 | +11.1% | 34,333 | -2.1% | 0.04% | +79.2% |
| Q2 2021 | $7,215,000 | -1.6% | 35,058 | -1.7% | 0.02% | -7.7% |
| Q1 2021 | $7,330,000 | -3.1% | 35,679 | +1.2% | 0.03% | -7.1% |
| Q4 2020 | $7,565,000 | +15.7% | 35,270 | -1.4% | 0.03% | -9.7% |
| Q3 2020 | $6,536,000 | -2.2% | 35,760 | -1.4% | 0.03% | -3.1% |
| Q2 2020 | $6,685,000 | -11.7% | 36,273 | -3.4% | 0.03% | -22.0% |
| Q1 2020 | $7,573,000 | +8.9% | 37,531 | +1.0% | 0.04% | +51.9% |
| Q4 2019 | $6,952,000 | +18.0% | 37,150 | +0.6% | 0.03% | +12.5% |
| Q3 2019 | $5,892,000 | -28.5% | 36,917 | +12.9% | 0.02% | -25.0% |
| Q2 2019 | $8,240,000 | +3.7% | 32,711 | -1.4% | 0.03% | +6.7% |
| Q1 2019 | $7,944,000 | +2.0% | 33,191 | -2.1% | 0.03% | -6.2% |
| Q4 2018 | $7,785,000 | -18.5% | 33,904 | +0.4% | 0.03% | 0.0% |
| Q3 2018 | $9,551,000 | +5.7% | 33,778 | +9.8% | 0.03% | +3.2% |
| Q2 2018 | $9,033,000 | -9.8% | 30,761 | -22.5% | 0.03% | -11.4% |
| Q1 2018 | $10,012,000 | +287.3% | 39,667 | +231.4% | 0.04% | +337.5% |
| Q4 2017 | $2,585,000 | +16.8% | 11,968 | +0.5% | 0.01% | 0.0% |
| Q3 2017 | $2,213,000 | +13.8% | 11,906 | +5.7% | 0.01% | +14.3% |
| Q2 2017 | $1,944,000 | +42.8% | 11,267 | +26.4% | 0.01% | +40.0% |
| Q1 2017 | $1,361,000 | -14.3% | 8,916 | -17.3% | 0.01% | -16.7% |
| Q4 2016 | $1,588,000 | -99.9% | 10,776 | -1.2% | 0.01% | +20.0% |
| Q3 2016 | $1,378,174,000 | +12.1% | 10,905 | +0.0% | 0.01% | 0.0% |
| Q2 2016 | $1,229,426,000 | +10.2% | 10,904 | +1.7% | 0.01% | +25.0% |
| Q1 2016 | $1,116,000,000 | -3.0% | 10,723 | +5.0% | 0.00% | -20.0% |
| Q4 2015 | $1,151,000,000 | +104157.2% | 10,209 | +1.3% | 0.01% | 0.0% |
| Q3 2015 | $1,104,000 | -99.9% | 10,081 | +1.0% | 0.01% | +25.0% |
| Q2 2015 | $954,400,000 | -8.4% | 9,977 | -10.8% | 0.00% | 0.0% |
| Q1 2015 | $1,042,051,000 | +27.1% | 11,188 | +11.7% | 0.00% | 0.0% |
| Q4 2014 | $820,065,000 | +24.0% | 10,013 | -2.8% | 0.00% | +33.3% |
| Q3 2014 | $661,375,000 | +6.0% | 10,305 | +0.4% | 0.00% | 0.0% |
| Q2 2014 | $623,850,000 | +2.5% | 10,259 | +1.0% | 0.00% | 0.0% |
| Q1 2014 | $608,501,000 | -3.1% | 10,162 | +3.1% | 0.00% | 0.0% |
| Q4 2013 | $628,117,000 | -5.6% | 9,859 | +0.6% | 0.00% | -25.0% |
| Q3 2013 | $665,442,000 | -8.7% | 9,796 | -3.2% | 0.00% | 0.0% |
| Q2 2013 | $729,103,000 | – | 10,118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |